Given a passage with a question and an answer to that question, classify if the answer actually answers the question into 'yes' or 'no'. Output 'yes' if the answer answers the question and output 'no' if the answer does not answer the question.

Q: Question: Does neo/adjuvant chemotherapy improve outcome in resected primary synovial sarcoma : a study of the French Sarcoma Group?
Answer: As for other high-grade soft-tissue sarcomas, well-planned wide surgical excision with adjuvant radiotherapy remains the cornerstone of treatment for SS. Neo-adjuvant or adjuvant chemotherapy should not be delivered outside a clinical trial setting.

A: no
****
Q: Question: Is variation in mortality among populations higher for pymetrozine than for imidacloprid and spiromesifen in Trialeurodes vaporariorum in greenhouses in Finland?
Answer: High variation in resistance levels to pymetrozine among populations within natural whitefly dispersal limits reflects variation in the usage of this compound among individual greenhouse crop producers. Thus, resistance management is recommended at the individual greenhouse crop producer level, even in a dense production cluster. © 2014 Society of Chemical Industry.

A: yes
****
Q: Question: Does [ SCF/c-Kit signaling promote invasion of T24 cells via PI3K pathway ]?
Answer: SCF/c-Kit signaling promotes the invasiveness of T24 cells, and this effect is mediated by the PI3K pathway.

A:
yes
****